CoChat

Effect of rifampicin treatment on hepatic drug metabolism and serum bile acids in patients with primary biliary cirrhosis

Hoensch, H. P., Balzer, K., Dylewizc, P., Kirch, W., Goebell, H., Ohnhaus, E. E. · 1985 · European Journal of Clinical Pharmacology

The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.

Abstract

Six patients with primary biliary cirrhosis (PBC) were treated with a daily oral dose of 600 mg rifampicin for 2 weeks to induce the hepatic metabolism of drugs and bile acids. On rifampicin 5 of 6 patients experienced a pronounced decrease of their pruritus. In all patients the oxidative cytochrome P-450 dependent drug metabolism was induced as shown by an increase of antipyrine-clearance from 36.3 +/- 8.8 to 80.6 +/- 20.1 ml/min and an enhanced urinary excretion of 6-beta-hydroxycortisol from 454 +/- 1.99 to 1607 +/- 362 micrograms/24 h. Furthermore, in all 6 patients the serum alkaline phosphatase declined. In the 3 cholestatic patients (bilirubin greater than 1.0 mg/dl) the serum concentration of total and conjugated bile acids was strikingly reduced. Thus, rifampicin is an inducer of hepatic metabolism in PBC-patients, ameliorates the pruritus and can lower serum concentrations of alkaline phosphatase and bile acids.

Overview

Integrity signals

Registry

Crossref · 10.1007/bf00544371

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Citations

Cites

Show all 10 references

Cited by

See all 76

Metadata

Authors
Hoensch, H. P., Balzer, K., Dylewizc, P., Kirch, W., Goebell, H., & Ohnhaus, E. E.
Affiliations
Essen University Hospital (DE)
Venue
European Journal of Clinical Pharmacology
Published
1985
Volume
28
Issue
4
Pages
475-477
ISSN
  • 0031-6970 (ISSN-L)
  • 1432-1041
OpenAlex
W1972626752
Cited by
76
References
10
Citations by year
2024: 2 · 2023: 1 · 2022: 2 · 2021: 1 · 2019: 1 · 2018: 1 · 2016: 1 · 2015: 4 · 2014: 2
FWCI
3.34
Type
journal article
Language
en
Open access
closed
Licence
www.springer.com/tdm (tdm)
Locations
  • European Journal of Clinical Pharmacology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
  • Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Drug-Induced Hepatotoxicity and Protection
Keywords
rifampicin, primary biliary cirrhosis, drug metabolism induction, cytochrome P450, bile acids, pruritus, antipyrine clearance, alkaline phosphatase, cholestasis, hepatic metabolism
MeSH terms
Adult, Alkaline Phosphatase, Antipyrine, Bile Acids and Salts, Humans, Liver, Liver Cirrhosis, Biliary, Middle Aged, Rifampin

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Effect of rifampicin treatment on hepatic drug metabolism and serum bile acids in patients with primary biliary cirrhosis. https://app.cochat.ai/papers/10.1007/bf00544371
The paper
Hoensch, H. P., Balzer, K., Dylewizc, P., Kirch, W., Goebell, H., & Ohnhaus, E. E. (1985). Effect of rifampicin treatment on hepatic drug metabolism and serum bile acids in patients with primary biliary cirrhosis. European Journal of Clinical Pharmacology. https://doi.org/10.1007/bf00544371

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.